LOGIN
No Clinical Benefit with 4 Weeks of Topical Diclofenac vs Placebo for Achilles Tendinopathy
April 2021
No Clinical Benefit with 4 Weeks of Topical Diclofenac vs Placebo for Achilles Tendinopathy
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Topical diclofenac vs placebo for the treatment of chronic Achilles tendinopathy: A randomized controlled clinical trial
PLoS One. 2021 Mar 4;16(3): e0247663.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Sixty-seven patients with Achilles tendinopathy were randomized to receive 4 weeks of daily topical diclofenac (n=32) or placebo (n=35) for the improvement of symptoms. The primary outcome of interest was physical function measured with the Victorian Institute of Sports Assessment - Achilles (VISA-A) score. Secondary outcomes of interest included pain at rest and during loading on a pain rating sc...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.